In their research, the proportions of IL-17+ T cells, CD8+ T cells, Foxp3+ Tregs, Tbet+ T cells, and CD20+ B cells in the central and invasive margins of postoperative tumor tissue from 82 patients (42 of whom received NACT) were analyzed. The gene discussed is CD8A; the disease is neoplasm.